How Obesity Accelerates Health Risks and Pain
Obesity, defined as a body mass index (BMI) of 30 or higher, is a significant public health concern linked to over 200 comorbidities, ranging from musculoskeletal pain to cardiometabolic and
Supplements to Consider with Meds Like Ozempic and Mounjaro
GLP-1 medications, such as Ozempic (semaglutide) and Mounjaro, are widely used for managing Type 2 diabetes and obesity. These medications can reduce appetite, which may lead to lower nutrient intake,
Medicaid Reforms Pass House in Budget Bill
On May 22, 2025, the House of Representatives passed H.R. 119, the “One Big Beautiful Bill Act,” in a razor-thin 215-214 vote, with only Republican support. Championed by President Donald
Major Trial to Test Drugs Like Ozempic for Cancer Prevention
A groundbreaking initiative in the UK aims to offer weight-loss injections, such as Ozempic, Wegovy, and Mounjaro, to tens of thousands of patients as a preventive measure against cancer. This
Microplastics are Everywhere in Your Kitchen
Microplastics are pervasive, infiltrating the air we breathe, the water we drink, the food we eat, and even our homes. These tiny plastic particles, smaller than 5 millimeters, and their
Linking Diabetes Meds to Weight Shifts
Diabetes, a chronic condition affecting millions worldwide, requires careful management to maintain blood sugar levels and prevent complications. While medications are a cornerstone of diabetes treatment, their impact on
The Top 10 Best-Selling Drugs in the US
The pharmaceutical industry continues to evolve, bringing innovative treatments to millions of Americans while driving significant economic growth. In 2024, the top-selling prescription drugs in the US
Trump’s Drug Tariffs Threaten U.S. Patients
Trump’s Proposed Tariffs on Canadian Drugs Could Raise Costs and Trigger Shortages in the U.S. The Trump administration is considering imposing tariffs on prescription drugs imported from Canada, a move
Januvia’s Price Drop Exposes the PBM Profit Game
In a twist that defies logic for many patients, Merck, the pharmaceutical giant behind the blockbuster diabetes drug Januvia (sitagliptin), slashed its price dramatically in early 2025.
Healthcare Costs Unraveled: A Literacy Blueprint for Savings
In an increasingly complex and expensive healthcare landscape, the ability to navigate medical costs has become a critical skill for individuals and families.
Is There an Overpayment Problem in Medicare Part D
Generic drugs make up 90% of all prescriptions filled in the US, offering a more affordable alternative to brand-name medications. However, research suggests that pharmacy benefit managers (PBMs) often reimburse
Mounjaro Might Benefit Your Heart Health
Mounjaro (tirzepatide) is primarily known for its role in managing Type 2 diabetes and supporting weight loss. However, growing evidence shows that this medication may also have significant benefits for
Tariff Speculation Puts Canada-U.S. Pharma Trade Under Scrutiny
The Canadian pharmaceutical sector is facing uncertainty as the U.S. government is still publicizing they will move forward with a 25% tariff on imported goods, including medications.
Hope for Neurological Disorders
How Neural Interfaces Are Transforming Neurological Care: A New Era of Possibilities The Growing Challenge of Neurological Conditions Chronic neurological conditions such as paralysis, Alzheimer’s, and Parkinson’s disease affect millions
The Importance of Daily Exercise
Engaging in daily exercise is crucial for maintaining and enhancing overall health. Regular physical activity has been shown to improve cardiovascular health, strengthen muscles and bones, and boost energy levels.